drugset / Trial / NCT01412437

Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria

NCT01412437 ↗

RandomizedParallel-groupOpen-labelDiagnostic

Summary

The investigators will use different types of brain imaging (MRI) in patients with Phenylketonuria (PKU) who are currently not on a strict diet to test the hypothesis that there is improvement in brain circuitry and biochemistry after return to diet and/or sapropterin dihydrochloride (Kuvan).

Timeline

Start
2011-04
Primary completion
2012-03
Completion
2012-12

Outcome

Outcome not reported

Stopped (Enrollment): “poor recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject sapropterin Unknown 10 mg/kg —
Subject sapropterin Unknown 20 mg/kg —

Indications